Description

FSL-1, a bacterial-derived toll-like receptor 2/6 (TLR2/6) agonist, enhances resistance to experimental HSV-2 infection[1][2].—COVID-19-immunoregulation–C84H140N14O18S—Int J Med Sci. 2022 Feb.|Food Res Int. 10 October 2022, 112029.|J Ethnopharmacol. 2024 Jan 24:117824.-[1]Rasheed Ahmad, et al. FSL-1 induces MMP-9 production through TLR-2 and NF-κB /AP-1 signaling pathways in monocytic THP-1 cells. Cell Physiol Biochem. 2014;34(3):929-42.|[2]William A Rose 2nd, et al. FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection. Virol J. 2009 Nov 10;6:195.–322455-70-9–1666.16—-O=C([C@H]1N(CCC1)C([C@H](CC(O)=O)NC(CNC([C@@H](N)CSCC(COC(CCCCCCCCCCCCCCC)=O)OC(CCCCCCCCCCCCCCC)=O)=O)=O)=O)N[C@@H](CCCCN)C(N[C@@H](CC2=CN=CN2)C(N3[C@@H](CCC3)C(N[C@@H](CCCCN)C(N[C@@H](CO)C(N[C@H](C(O)=O)CC4=CC=CC=C4)=O)=O)=O)=O)=O–Infection–H2O–Antibiotic;Toll-like Receptor (TLR)–TLR2;TLR6–Anti-infection;Immunology/Inflammation–Peptides